CD44 and metastatic malignant neoplasm in the lymph nodes: Additionally, CD44 was shown to be associated with some clinicopathological features, such as lymph node metastasis (OR<sub>CD44</sub> = 1.56, 95% CI = 1.01-2.41, <i>P</i> = 0.044; OR<sub>CD44v6</sub> = 1.97, 95% CI = 1.19-3.26, <i>P</i> = 0.008; OR<sub>Total CD44 isoforms</sub> = 1.57, 95% CI = 1.15-2.14, <i>P</i> = 0.004), distant metastasis (OR<sub>CD44</sub> = 2.90, 95% CI = 1.08-7.83, <i>P</i> = 0.035; OR<sub>Total CD44 isoforms</sub> = 1.89, 95% CI = 1.02-3.53, <i>P</i> = 0.044).